Comparison of Myofascial Release and Mulligan Concept Techniques in Patients With Cervicogenic Headache
Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Nov 13, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two types of physical therapy techniques—Mulligan Concept and myofascial release—to see how well they help people with cervicogenic headaches, which are headaches caused by issues in the neck. The researchers want to find out if these treatments can improve various aspects of life for participants, including reducing pain, improving strength and movement in the neck, and decreasing the need for medication.
To participate, individuals need to be between 25 and 60 years old, have been diagnosed with cervicogenic headaches for more than three months, and experience neck pain along with their headaches. Participants will receive either the Mulligan Concept or myofascial release therapy three times a week for four weeks and will keep track of their symptoms and medication use. This study is currently recruiting participants, and it aims to provide valuable insights into effective treatments for cervicogenic headaches.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having been diagnosed with cervicogenic headache according to the International Classification of Headache Disorder-III diagnostic criteria
- • Having been diagnosed with cervicogenic headache for more than 3 months
- • Having a headache accompanying neck pain
- • Having restricted neck joint movement according to the Flexion-Rotation Test
- • Having pain between 3 and 8 according to the Visual Analog Scale
- • Being between 25-60 years of age
- • Agreeing to participate in the study voluntarily
- Exclusion Criteria:
- • Previous cervical surgery
- • Previous cervical trauma
- • Having received diagnosis-related physiotherapy in the last 6 months
- • Diagnosis of tumor or cancer
- • Having other types of headache
- • Serious cardiovascular, cerebrovascular, hematological, metabolic, neurological or mental disease
- • Being pregnant or breastfeeding
- • Having red flags for manual therapy
- • Dizziness with headache, visual disturbance
- • Congenital cervical disorder
- • Rheumatoid arthritis, cervical spondylolisthesis, cervical instability, infection
About Istanbul Medipol University Hospital
Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported